A-fib and Cirrhosis alcoholic
Cirrhosis alcoholic is reported only by a few people with A-fib.
The study analyzes which people have Cirrhosis alcoholic with A-fib. It is created by eHealthMe based on 5 people who have Cirrhosis alcoholic and A-fib from the Food and Drug Administration (FDA), and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
5 people who have A-Fib and Cirrhosis Alcoholic are studied.
What is A-fib?
A-fib (most common type of arrhythmia) is found to be associated with 3,471 drugs and 3,304 conditions by eHealthMe.
What is Cirrhosis alcoholic?
Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 358 drugs and 156 conditions by eHealthMe.
Number of Cirrhosis alcoholic in A-fib reports submitted per year:
Gender of people who have A-Fib and experienced Cirrhosis Alcoholic *:
- female: 0.0 %
- male: 100 %
Age of people who have A-Fib and experienced Cirrhosis Alcoholic *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common co-existing conditions for these people *:
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 20.00%
- Prerenal Failure: 1 person, 20.00%
- Mantle Cell Lymphoma Stage Iv (cancer of lymphocytes, a type of white blood cell, spreads to other part of body): 1 person, 20.00%
- Diabetes: 1 person, 20.00%
Common drugs taken by these people *:
- Pradaxa: 2 people, 40.00%
- Xarelto: 1 person, 20.00%
- Pepcid: 1 person, 20.00%
- Losartan: 1 person, 20.00%
- Lasix: 1 person, 20.00%
- Lantus: 1 person, 20.00%
- Januvia: 1 person, 20.00%
- Glucophage: 1 person, 20.00%
- Digoxin: 1 person, 20.00%
- Aldactone: 1 person, 20.00%
Common symptoms for these people *:
- Anaemia (lack of blood): 2 people, 40.00%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 40.00%
- Splenomegaly (enlargement of spleen): 2 people, 40.00%
- Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 40.00%
- Weight Decreased: 1 person, 20.00%
- Haematochezia (passage of stools containing blood): 1 person, 20.00%
- Duodenal Ulcer Haemorrhage (bleeding duodenal ulcer): 1 person, 20.00%
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 1 person, 20.00%
- Fatigue (feeling of tiredness): 1 person, 20.00%
- Gastric Ulcer Haemorrhage (bleeding ulcer of stomach): 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Cirrhosis alcoholic?Check whether Cirrhosis alcoholic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Cirrhosis alcoholic:
- Cirrhosis alcoholic in Moderna COVID Vaccine
- Cirrhosis alcoholic in Pfizer BioNTech Covid Vaccine
- Cirrhosis alcoholic in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (358 drugs)
All the conditions that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (156 conditions)
How the study uses the data?
The study is based on Cirrhosis alcoholic and A-fib, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.